2018
Cost-Related Insulin Underuse Is Common and Associated with Poor Glycemic Control
HERKERT D, VIJAYAKUMAR P, LUO J, SCHWARTZ J, RABIN T, DEFILIPPO E, LIPSKA K. Cost-Related Insulin Underuse Is Common and Associated with Poor Glycemic Control. Diabetes 2018, 67 DOI: 10.2337/db18-2-or.Peer-Reviewed Original ResearchCost-related underusePoor glycemic controlGlycemic controlDiabetes CenterCross-sectional surveyDM durationPrimary outcomeLess insulinHigher oddsPatientsSmall dosesDrug coverageLogistic regressionInsulinUnderuseMedicaid ServicesEssential medicinesNational InstituteInsulin 3Lower income levelsInsulin 5AgePositive responseHealthUrgent needUnderuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review
Hsu JC, Freeman JV. Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review. Clinical Pharmacology & Therapeutics 2018, 104: 301-310. PMID: 29328506, DOI: 10.1002/cpt.1024.Peer-Reviewed Original ResearchConceptsAtrial fibrillationStroke preventionVitamin K antagonistsDirect oral anticoagulantsNonvalvular AF patientsOral anticoagulant therapyRisk of strokeSpecial patient populationsSerious clinical problemOAC therapyK antagonistsOral anticoagulantsAnticoagulant therapyAF patientsPatient populationLeading causeClinical problemPatientsSignificant deleterious impactPreventionFibrillationTherapyContemporary reviewStrokeUnderuse
2017
Racial Disparities in Clinically Significant Prostate Cancer Treatment: The Potential Health Information Technology Offers
Bickell N, Lin J, Abramson S, Hoke G, Oh W, Hall S, Stock R, Fei K, McAlearney A. Racial Disparities in Clinically Significant Prostate Cancer Treatment: The Potential Health Information Technology Offers. JCO Oncology Practice 2017, 14: jop.2017.025957. PMID: 29194001, PMCID: PMC5765902, DOI: 10.1200/jop.2017.025957.Peer-Reviewed Original ResearchConceptsTreatment underuseRacial disparitiesBlack menHealth information technology capabilitiesWhite menCancer care qualityPoor quality careInterviewed treating physiciansInformation technology-based solutionsCare qualityQuality careCancer careReduce disparitiesUrban hospitalsProstate cancerRate of prostate cancerUnderuseCareTechnology-based solutionsAge-matched white menTreatment ratesDisparitiesClinically Significant Prostate CancerHealthSignificant prostate cancer
2008
Getting By: Underuse of Interpreters by Resident Physicians
Diamond LC, Schenker Y, Curry L, Bradley EH, Fernandez A. Getting By: Underuse of Interpreters by Resident Physicians. Journal Of General Internal Medicine 2008, 24: 256-262. PMID: 19089503, PMCID: PMC2628994, DOI: 10.1007/s11606-008-0875-7.Peer-Reviewed Original ResearchConceptsLimited English proficiencyInterpreter useResident physiciansProfessional interpretersSecond language skillsUrban teaching hospitalEvidence of benefitPhysician-patient communicationResident physician useQuality of careOwn time constraintsValue of communicationEnglish proficiencyLanguage skillsInterpreter servicesTeaching hospitalInterpretersPhysician useClinical decisionStudy institutionPhysiciansDesignQualitative studyRecurrent themesIndividual physiciansUnderuse
2003
Patient characteristics associated with underuse of angiotensin-converting enyzme inhibitors among elderly medicare beneficiaries hospitalized for heart failure
Rathore S, Masoudi F, Wang Y, Foody J, Havranek E, Krumholz H. Patient characteristics associated with underuse of angiotensin-converting enyzme inhibitors among elderly medicare beneficiaries hospitalized for heart failure. Journal Of Cardiac Failure 2003, 9: s85. DOI: 10.1016/s1071-9164(03)00153-2.Peer-Reviewed Original Research
1997
Adverse Outcomes of Underuse of β-Blockers in Elderly Patients-Reply
Soumerai S, McLaughlin T, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse Outcomes of Underuse of β-Blockers in Elderly Patients-Reply. JAMA 1997, 277: 1436-1437. DOI: 10.1001/jama.1997.03540420032022.Peer-Reviewed Original ResearchCalcium channel blockersChannel blockersΒ-blockersNondihydropyridine calcium channel blockersNational evidence-based guidelinesDihydropyridine calcium channel blockerΒ-blocker useAdministrative claims databaseLipid-lowering agentsEvidence-based guidelinesEffective drug classClaims databaseAdverse outcomesDrug classesComparative efficacyBlockersCommunity settingsPatients' repliesAspirinPrevious reportsUnderuseOutcomesPatientsTrials
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply